| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review | Journal of Pain and Symptom Management | 2011 | 1.3K |
| The landscape of cancer genes and mutational processes in breast cancer | Nature | 2012 | 1.3K |
| Comprehensive genomic profiles of small cell lung cancer | Nature | 2015 | 1.1K |
| Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer | Science Translational Medicine | 2010 | 646 |
| Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies | Annals of Oncology | 2014 | 620 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology and Hepatology | 2016 | 618 |
| Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study | Annals of Oncology | 2013 | 598 |
| Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial | Lancet Oncology, The | 2015 | 475 |
| Dabrafenib plus trametinib in patients with previously untreated BRAF-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial | Lancet Oncology, The | 2017 | 461 |
| Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study | Journal of Clinical Oncology | 2012 | 416 |
| A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma | Journal of Translational Medicine | 2011 | 412 |
| Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol | European Heart Journal | 2016 | 361 |
| Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 316 |
| Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries | JAMA - Journal of the American Medical Association | 2016 | 308 |
| Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes | Oncogene | 2016 | 293 |
| Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project | Blood | 2011 | 290 |
| A review of the evolution of systemic chemotherapy in the management of colorectal cancer | Clinical Colorectal Cancer | 2015 | 289 |
| Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs | Cancer Treatment Reviews | 2017 | 272 |
| Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial | JAMA - Journal of the American Medical Association | 2014 | 264 |
| miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors | PLoS ONE | 2011 | 258 |
| Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial | Lancet Oncology, The | 2016 | 253 |
| The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies | Clinical and Translational Radiation Oncology | 2018 | 252 |
| Principles and methods of integrative genomic analyses in cancer | Nature Reviews Cancer | 2014 | 245 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia | Nature Medicine | 2018 | 235 |
